Back to NTLA

Intellia Therapeutics, Inc. 10-Q

Accession 0000950170-23-062011

Filing information

CIK
0001652130
Report date
2023-09-30
Filing date
2023-11-09
Form
10-Q
Primary document
ntla-20230930.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.